首页> Clinical Endocrinology> A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study.

A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study.

导出原文传递

翻译打印收藏纠错

第一作者： Sathyapalan T

作者： Sathyapalan T ^[1] ; Cho LW ; Kilpatrick ES ; Coady AM ; Atkin SL

作者单位： Department of Diabetes and Endocrinology, University of Hull, Hull, UK. ^[1]

关键词 Metformin Insulin Resistance Weight Polycystic Ovary Syndrome 二甲双胍胰岛素抗药性多囊卵巢综合征

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical Endocrinology

2008年69卷6期

931-935页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Clinical Endocrinology

2008年69卷6期

931-935页

检索历史清除

A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study.

Clinical Endocrinology

相似文献

同项目论文

Clinical Endocrinology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study.

Clinical Endocrinology

相似文献

同项目论文

Clinical Endocrinology

相关期刊

检索历史清除